Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial in Healthy Male Volunteers To Examine The Safety, Tolerability, And Pharmacokinetics Of HMPL-011 After A Single Dose.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs HMPL 011 (Primary)
- Indications Inflammation; Multiple sclerosis; Rheumatoid arthritis
- Focus Adverse reactions
- 25 Jul 2011 Status changed from not yet recruiting to completed.
- 20 Oct 2009 New trial record